CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)		Total	Common Stock		Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023	[1]		492,304
Beginning balance at Dec. 31, 2023		$ 5,287,282	$ 49	[1]	$ 81,635,074	$ (76,347,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		47,000
Issuance of equity securities, net		38	$ 5	[1]	33
Equity-based compensation expense		77,508			77,508
Net loss		(1,715,290)				(1,715,290)
Ending balance (in shares) at Mar. 31, 2024	[1]		539,304
Ending balance at Mar. 31, 2024		$ 3,649,538	$ 54	[1]	81,712,615	(78,063,131)
Beginning balance (in shares) at Dec. 31, 2024		1,441,157	1,441,157	[1]
Beginning balance at Dec. 31, 2024		$ 1,511,695	$ 144	[1]	83,435,169	(81,923,618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of equity securities, net (in shares)	[1]		640,682
Issuance of equity securities, net		226,170	$ 64	[1]	226,106
Equity-based compensation expense		33,534			33,534
Net loss		$ (1,709,533)				(1,709,533)
Ending balance (in shares) at Mar. 31, 2025		2,081,839	2,081,839	[1]
Ending balance at Mar. 31, 2025		$ 61,866	$ 208	[1]	$ 83,694,809	$ (83,633,151)

[1] Share and per share amounts have been restated to reflect the 1-for-8 reverse stock split effected in June 14, 2024 on retroactive basis for all periods presented.